BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 12.75
-0.15 (-1.16%)
Nov 21, 2025, 5:00 PM CET
BioMaxima Market Cap
BioMaxima has a market cap or net worth of 53.46 million as of November 21, 2025. Its market cap has decreased by -11.15% in one year.
Market Cap
53.46M
Enterprise Value
69.33M
Revenue
57.05M
Ranking
n/a
PE Ratio
76.50
Stock Price
12.75
Market Cap Chart
Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 53.46M, an increase of 368.82%. That is a compound annual growth rate of 10.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 53.46M | 19.16% |
| Dec 30, 2024 | 44.87M | -34.84% |
| Dec 29, 2023 | 68.85M | -35.28% |
| Dec 30, 2022 | 106.38M | -6.37% |
| Dec 30, 2021 | 113.62M | -4.71% |
| Dec 30, 2020 | 119.23M | 792.90% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.94B |
| NEUCA | 3.62B |
| Synektik Spólka Akcyjna | 2.22B |
| Voxel | 1.51B |
| Celon Pharma | 1.08B |
| Selvita | 805.81M |
| Centrum Medyczne ENEL-MED | 523.19M |
| Bioceltix | 447.63M |